Associated Papers
Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid Cancers.
Subramanian J et al.
The Oncologist, 2019
Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature.
Petrelli F et al.
Breast Cancer Research and Treatment, 2017
HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.
Wang T et al.
Cancer Science, 2017
Select a paper to view details